Nataliia Herbina

Mrs. Nataliia Herbina


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DKDalia Marija Kopustinskiene
Dalia Marija Kopustinskiene
UBUrte Bernatonyte
Urte Bernatonyte
Yuliia MasliiYuliia Maslii
Yuliia Maslii
NHNataliia Herbina
Nataliia Herbina
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
Pain is the predominant symptom of many clinical diseases and is frequently associated with neurological and musculoskeletal problems. Chronic pain is frequent in the elderly, causing suffering, disability, social isolation, and increased healthcare expenses. Chronic pain medication is often ineffective and has many side effects. Nonsteroidal over-the-counter and prescription drugs are frequently recommended as first-line therapies for pain control; however, long-term safety issues must not be neglected. Herbs and nutritional supplements may be a safer and more effective alternative to nonsteroidal pharmaceuticals for pain management, especially when used long-term. Recently, topical analgesic therapies have gained attention as an innovative approach due to their sufficient efficacy and comparatively fewer systemic side effects and drug–drug interactions. In this paper, we overview the main natural herbal pain relievers, their efficacy and safety, and their potential use as topical agents for pain control. Although herbal-derived medications are not appropriate for providing quick relief for acute pain problems, they could be used as potent alternative remedies in managing chronic persistent pain with minimal side effects.

5 March 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GKGiedrė Kasparavičienė
Giedrė Kasparavičienė
Yuliia MasliiYuliia Maslii
Yuliia Maslii
NHNataliia Herbina
Nataliia Herbina
DKDaiva Kazlauskiene
Daiva Kazlauskiene
MMMindaugas Marksa
Mindaugas Marksa
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
The formulation of biphasic gels as potential semi-solid carriers for hydrophilic and lipophilic active substances is promising for the development of pharmaceutical preparations. The aim of this study was to design a stable bigel composition and to determine the influence of the organogel/hydrogel ratio on the gel’s physical-chemical and structural-mechanical properties. The investigated compositions of organogel/hydrogel remained stable at ratios ranging from 5/95 to 40/60. After texture and microstructure analysis, bigels with 20/80 and 25/75 ratios were selected as carriers for the active ingredients, sodium diclofenac and camphor, for use as topical preparations for the treatment of muscle-joint inflammation and pain. Although other researchers have published data on the preparation and evaluation of bigels, there are no scientific results on the development of a two-phase gel with our proposed combination of APIs. Sodium diclofenac release was found to be higher when combined with camphor, which revealed the advantages of the biphasic formulation. The pseudoplastic behavior, thixotropy, and thermal stability of flow of the studied bigel samples was investigated by rheological analysis. Ongoing stability studies confirmed the minimal 6-month period.

19 September 2024 in Polymers
Verified
Journal Article
Open access
PDF file
Yuliia MasliiYuliia Maslii
Yuliia Maslii
NHNataliia Herbina
Nataliia Herbina
LDLina Dėnė
Lina Dėnė
LILiudas Ivanauskas
Liudas Ivanauskas
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
According to data in the literature, natural products and essential oils are often used in dental practice. To develop a new oromucosal spray for the treatment of infectious and inflammatory diseases of the oral cavity, clove CO2 extract and essential oils of lavender and grapefruit were used as active pharmaceutical ingredients. Clove extract was obtained by the method of subcritical extraction from various raw materials, the choice of which was based on the yield of the CO2 extract and the study of its phytochemical and microbiological properties. Based on the results of microscopic and diffraction analyses, the rational time of ultrasonic exposure for the emulsion of active pharmaceutical ingredients was established. Mucoadhesive polymers were used as stabilizers of the two-phase system and prolongators. This article discusses the impact of the type and concentration of mucoadhesive polymers on the stability of the emulsion system; the viscous, textural, adhesive, and film characteristics of oromucosal spray; and the parameters determining sprayability.

20 January 2025 in Plants
Verified
Journal Article
Open access
PDF file
Olha MykhailenkoOlha Mykhailenko
Olha Mykhailenko
VNViktoriia Nechepurenko
Viktoriia Nechepurenko
NHNataliia Herbina
Nataliia Herbina
Yuliia MasliiYuliia Maslii
Yuliia Maslii
LILiudas Ivanauskas
Liudas Ivanauskas
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
The search for neuroprotective compounds in lavender is driven by its traditional use for brain health, with antioxidant activity serving as a key mechanism in reducing oxidative stress and supporting cognitive function. Lavender’s potential to protect neurons is based on its calming, anti-stress properties, which increase the brain’s resistance to neurodegeneration. Although lavender is not a traditional medicinal plant in Ukraine, it is increasingly recognised for its medicinal properties and is widely cultivated in the country. Lavender use in Ukraine is influenced by both global herbal practices and local medical traditions. The aim of this study was to optimise the preparation of lavender herb extracts, perform chemical profiling and evaluate their antioxidant and neuroprotective activities. The study focused on Lavandula angustifolia cultivated in Lviv, Ukraine. Modern analytical methods were used, including HPLC, spectrophotometry, molecular docking, lyophilisation and pharmacological testing. The selection of the optimal conditions for obtaining lavender herb extracts was determined on the basis of the results of the total yield of phenolic compounds in each extract, where it was found that the raw material–solvent ratio (1:10) in water and 50% ethanol gave the highest yield of substances; the preferred extraction time was 20 min, and the temperature was 60–70 °C, especially for water extraction. Further HPLC analysis identified marker compounds including rosmarinic acid (28.31 mg/g), chlorogenic acid (1.64 mg/g) and luteolin (0.23 mg/g) in the lyophilised ethanol extract, which were previously recognised as neuroprotective markers by molecular docking. The water extract showed higher antioxidant (total 50.85 mg/g) and neuroprotective activity, probably due to synergistic interactions among the components. Behavioural tests further demonstrated the neuroprotective potential of lavender herb. These results demonstrate the potential neuroprotective activity of lavender herb and open new possibilities for its use in the treatment of various neurodegenerative diseases.

5 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Yuliia MasliiYuliia Maslii
Yuliia Maslii
LGLiudmyla V. Garmanchuk
Liudmyla V. Garmanchuk
OROlena Ruban
Olena Ruban
TDTaisa Dovbynchuk
Taisa Dovbynchuk
NHNataliia Herbina
Nataliia Herbina
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
Medicated chewing gum with lysozyme hydrochloride and ascorbic acid as active pharmaceutical ingredients was developed for application in dentistry. The aim of this research was to study the cytotoxicity, proliferative, and microbiological activities of the active ingredients in different types of cell cultures. The preclinical study of active pharmaceutical ingredients and their combinations was carried out using culture lines such as HepG2 (human hepatocarcinoma cells), Hek293 (human embryonic kidney cells), and MAEC (mouse aortic endothelial cells). MTT assays were used to analyse cytotoxicity and proliferative activity, while the state of antioxidant protection was assessed by the content of sulfhydryl groups and catalase activity. The determination of lipid peroxidation products was based on the level of TBA-active products. As a microbiological model for studying the effect of the developed dental medicine on the ability of the oral cavity microorganisms to form biofilms, the following strains were used: Streptococcus mutans, Staphylococcus aureus, Staphylococcus epidermidis, Lactobacillus plantarum, and Candida albicans. The optical density of the formed biofilm was evaluated by the intensity of the experimental sample’s colour on a StatFax 303 Plus photometer at a wavelength of 630 nm. The combination of ascorbic acid and lysozyme hydrochloride in the established concentrations (20 mg and 10 mg per 1 gum, respectively) resulted in a slight stimulation of cell proliferation without any toxic effects and increased antioxidant protection, preventing the development of oxidative stress. It was found that, in contrast to the separately used active substances, the combination of lysozyme hydrochloride and ascorbic acid inhibits the biofilm formation of all studied microorganisms and shows the ability to destroy diurnal biofilms of L. plantarum and fungi of the genus Candida, indicating potentiation and summation of the active pharmaceutical ingredients’ composition effects in the developed dental medicine. Due to the observed positive pharmacological and microbiological action, the combination of lysozyme hydrochloride and ascorbic acid in the medicated chewing gum serves as a promising tool for the prevention and treatment of infectious and inflammatory diseases of the periodontium and mucous membranes and the prevention of caries.

26 March 2019 in Likars'ka Sprava
Verified
Journal Article
Open access
LIL. B. Ivantsyk
L. B. Ivantsyk
SDS. M. Drogovoz
S. M. Drogovoz
NHNataliia Herbina
Nataliia Herbina
ККК. А. Каlко
К. А. Каlко
VSV. V. Shtroblia
V. V. Shtroblia
An experimental study of a new combined ointment with ethony for treatment of wounds was carried out and its advantages were established compared with the similar drugs Inflarax (LLC FC "Health"), Levomekol (ZAO SPC "Borshchagovsky HFZ") and Oflokain-Darnitsa® (ZAO FF "Darnitsa"), having the same indications for use as a new ointment. The osmotic activity of ointment with ethony was studied by the method of kinetics of water absorption in in vitro experiments. The antimicrobial effect of ointment with ethony relative to standard and hospital strains of microorganisms by diffusion in agar in the modification of wells was determined: S. aureus ATCC 25923, E. coli ATCC 25922, P. aeruginosa ATCC 27853, B. subtilis ATCC 6633, P. vulgaris ATCC 4636, C. albicans ATCC 885/653, S. aureus 23, E. coli 15, P. aeruginosa 39, P. vulgaris 59, K. pneumoniae 6. The anti-inflammatory activity of ointment with ethony was established in a model of non-allergic contact dermatitis caused by turpentine. The results of experimental studies indicate the high efficiency of the proposed combined composition of the ointment with ethony due to the optimal combination of the components of the ointment base and active substances. It was established that the ointment with ethony showed a pronounced and prolonged osmotic activity, which contributes to the complete penetration and release of the active substances of the ointment in the tissue. An ointment with ethony revealed a wide spectrum of antimicrobial activity with respect to standard and hospital strains: with respect to C. albicans ATCC 885/653 and K. pneumoniae 6, this ointment was superior in activity to all comparison drugs. The ointment with ethony showed a pronounced anti-inflammatory effect, superior to the comparison drugs in effectiveness. Thus, due to the presence of a wide spectrum of pharmacological activity, ethony ointment can be recommended for the treatment of wounds with severe exudation in the first phase of the wound process, for wounds infected with mixed bacterial and fungal microflora, and for the prevention of their complications, as well as in complex therapy of the skin inflammatory processes.